{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:18:57Z","timestamp":1790745537474,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Foundation for Research of the Rio de Janeiro State (FAPERJ)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Improvement Coordination (CNPq)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Teaching Personnel Improvement Coordination (CAPES)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Federal Fluminense University (UFF)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.micpath.2018.03.024","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T16:20:06Z","timestamp":1521390006000},"page":"105-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms"],"prefix":"10.1016","volume":"118","author":[{"given":"Juliana S.","family":"Novais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina J.A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel S.","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes Marie","family":"S\u00e1 Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor F.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena C.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7928-8646","authenticated-orcid":false,"given":"David R.","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2018.03.024_bib1","author":"World Health Organization, WHO"},{"key":"10.1016\/j.micpath.2018.03.024_bib2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1378\/chest.14-2171","article-title":"Antimicrobial resistance in hospital-acquired Gram-negative bacterial infections","volume":"147","author":"Mehrad","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.micpath.2018.03.024_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13054-016-1320-7","article-title":"Antibiotic strategies in the era of multidrug resistance","volume":"20","author":"Karam","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.micpath.2018.03.024_bib4","first-page":"7","article-title":"Pseudomonas aeruginosa ventilator-associated pneumonia management","volume":"9","author":"Ram\u00edrez-Estrada","year":"2016","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2018.03.024_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5492\/wjccm.v5.i2.111","article-title":"Association between infections caused by multidrug-resistant Gram-negative bacteria and mortality in critically ill patients","volume":"5","author":"Paramythiotou","year":"2016","journal-title":"World J. Crit. Care Med."},{"key":"10.1016\/j.micpath.2018.03.024_bib6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fphar.2017.00546","article-title":"Interplay of the quality of ciprofloxacin and antibiotic resistance in developing countries","volume":"8","author":"Sharma","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2018.03.024_bib7","doi-asserted-by":"crossref","first-page":"17001","DOI":"10.1038\/nmicrobiol.2017.1","article-title":"Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bact\u00e9ria","volume":"2","author":"Masi","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.micpath.2018.03.024_bib8","doi-asserted-by":"crossref","first-page":"E5034","DOI":"10.1073\/pnas.1602382113","article-title":"Gram-negative trimeric porins have specific LPS binding sites that are essential for porin biogenesis","volume":"113","author":"Arunmanee","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.micpath.2018.03.024_bib9","first-page":"12","article-title":"Antibiotic resistance: what is so special about multidrug-resistant Gram-negative bacteria?","volume":"10","author":"Exner","year":"2017","journal-title":"GMS Hyg. Infect. Control"},{"key":"10.1016\/j.micpath.2018.03.024_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13613-015-0061-0","article-title":"Mechanisms of antimicrobial resistance in Gram-negative bacilli","volume":"5","author":"Rupp\u00e9","year":"2015","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.micpath.2018.03.024_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with Gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2018.03.024_bib12","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/cc13697","article-title":"Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes","volume":"18","author":"Lu","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.micpath.2018.03.024_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fcimb.2017.00039","article-title":"Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence","volume":"7","author":"Moradali","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2018.03.024_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jgar.2017.06.011","article-title":"Resistance to quinolones, cephalosporins and macrolides in Escherichia coli causing bacteraemia in Peruvian children","volume":"11","author":"Palma","year":"2017","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.micpath.2018.03.024_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12941-017-0227-8","article-title":"Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study","volume":"16","author":"Su","year":"2017","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.micpath.2018.03.024_bib16","doi-asserted-by":"crossref","DOI":"10.1590\/1807-3107bor-2017.vol31.0038","article-title":"Association between pathogens from tracheal aspirate and oral biofilm of patients on mechanical ventilation","volume":"31","author":"Souza","year":"2017","journal-title":"Braz. Oral Res."},{"key":"10.1016\/j.micpath.2018.03.024_bib17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/pathogens3030596","article-title":"Biomolecular mechanisms of Pseudomonas aeruginosa and Escherichia coli biofilm formation","volume":"3","author":"Laverty","year":"2014","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2018.03.024_bib18","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3389\/fmicb.2016.01763","article-title":"Some like it hot: heat resistance of Escherichia coli in food","volume":"7","author":"Li","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2018.03.024_bib19","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1016\/j.bmc.2016.05.004","article-title":"Drug discovery strategies to outer membrane targets in Gram-negative pathogens","volume":"24","author":"Brown","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib20","first-page":"73","article-title":"Antibacterial and cytotoxic activities of naphthoquinone pigments from Onosma visianii Clem","volume":"16","author":"Vukic","year":"2017","journal-title":"EXCLI J."},{"key":"10.1016\/j.micpath.2018.03.024_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/molecules22020302","article-title":"Efficient catalytic oxidation of 3-arylthio- and 3-cyclohexylthio-lapachone derivatives to new sulfonyl derivatives and evaluation of their antibacterial activities","volume":"22","author":"Cardoso","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2018.03.024_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/wound.2011.0301","article-title":"Molecular mechanisms of biofilm infection: biofilm virulence factors","volume":"1","author":"Phillips","year":"2012","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"10.1016\/j.micpath.2018.03.024_bib23","first-page":"1","article-title":"Carriage, clinical microbiology and transmission of Staphylococcus aureus","author":"Aryee","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2018.03.024_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2018.03.024_bib25","first-page":"9584703","article-title":"Inhibition of Pseudomonas aeruginosa biofilm formation by traditional Chinese Medicinal Herb Herba patriniae","author":"Fu","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2018.03.024_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MB-0016-2014","article-title":"New technologies for studying biofilms","volume":"3","author":"Franklin","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2018.03.024_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/microbiolspec.MB-0011-2014","article-title":"Bacterial extracellular polysaccharides in biofilm formation and function","volume":"3","author":"Limoli","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2018.03.024_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/ph8040696","article-title":"Controlling persister and biofilm cells of Gram-negative bacteria with a new 1,3,5-triazine derivative","volume":"8","author":"Bahar","year":"2015","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.micpath.2018.03.024_bib29","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1021\/acs.jmedchem.5b01698","article-title":"Novel strategies for the treatment of Pseudomonas aeruginosa infections","volume":"59","author":"Wagner","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012427","article-title":"Bacterial quorum sensing: its role in virulence and possibilities for its control","volume":"2","author":"Rutherford","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.micpath.2018.03.024_bib31","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bmc.2005.09.054","article-title":"Synthesis and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum","volume":"14","author":"Baramee","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ejmech.2015.09.001","article-title":"Novel 1,4-naphthoquinone-based sulfonamides: synthesis, QSAR, anticancer and antimalarial studies","volume":"103","author":"Pingaew","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13567-016-0317-1","article-title":"Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model","volume":"47","author":"M\u00fcller","year":"2016","journal-title":"Vet. Res."},{"key":"10.1016\/j.micpath.2018.03.024_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105127","article-title":"Potential of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinones against Leishmania (L.) infantum: biological activity and structure-activity relationships","volume":"9","author":"Pinto","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2018.03.024_bib35","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1016\/j.bmc.2006.04.046","article-title":"Trypanocidal agents with low cytotoxicity to mammalian cell line: a comparison of the theoretical and biological features of lapachone derivatives","volume":"14","author":"Ferreira","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib36","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0020-7519(00)00114-4","article-title":"Molluscicidal activity of 2-hydroxy-3-alkyl-1,4-naphthoquinones and derivatives","volume":"30","author":"dos Santos","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.micpath.2018.03.024_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molbiopara.2011.01.002","article-title":"Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistance","volume":"177","author":"Hughes","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.micpath.2018.03.024_bib38","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1021\/acs.jafc.6b03309","article-title":"Enhancement of antifungal activity of juglone (5-Hydroxy-1,4-naphthoquinone) using a poly(d,l-lactic-co-glycolic acid) (PLGA) nanoparticle system","volume":"64","author":"Arasoglu","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1590\/S0103-50532013000100003","article-title":"A new approach for the synthesis of 3-substituted cytotoxic nor-\u03b2-lapachones","volume":"24","author":"Cardoso","year":"2013","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.micpath.2018.03.024_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ps.445","article-title":"Insecticidal 2-hydroxy-3-alkyl-1,4-naphthoquinones: correlation of inhibition of ubiquinol cytochrome c oxidoreductase (complex III) with insecticidal activity","volume":"58","author":"Jewess","year":"2002","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.micpath.2018.03.024_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jep.2017.04.029","article-title":"Anti-inflammatory action of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) suppresses both the MyD88-dependent and TRIF-dependent pathways of TLR4 signaling in LPS-stimulated RAW264.7 cells","volume":"205","author":"Ju Woo","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micpath.2018.03.024_bib42","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1016\/j.bmc.2010.06.105","article-title":"Antiviral agents 2. Synthesis of trimeric naphthoquinone analogues of conocurvone and their antiviral evaluation against HIV","volume":"18","author":"Crosby","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3851\/IMP3039","article-title":"Aminomethylnaphthoquinones and HSV-1: in vitro and in silico evaluations of potential antivirals","volume":"21","author":"Pires de Mello","year":"2016","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.micpath.2018.03.024_bib44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0161-6420(99)90021-0","article-title":"Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients","volume":"106","author":"Pearson","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.micpath.2018.03.024_bib45","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJM200011163432004","article-title":"Atovaquone and azithromycin for the treatment of babesiosis","volume":"343","author":"Krause","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2018.03.024_bib46","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1086\/343750","article-title":"Atovaquone\/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity","volume":"35","author":"Lacy","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.03.024_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02236507","article-title":"Treatment of theileriosis in crossbred cattle in the Punjab","volume":"25","author":"Singh","year":"1993","journal-title":"Trop. Anim. Health Prod."},{"key":"10.1016\/j.micpath.2018.03.024_bib48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/jac\/dkm303","article-title":"In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs","volume":"60","author":"Garnier","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2018.03.024_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S0103-50532001000300004","article-title":"Synthesis and antimicrobial evaluation of 3-hydrazino-naphthoquinones as analogs of lapachol","volume":"12","author":"Oliveira","year":"2001","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.micpath.2018.03.024_bib50","doi-asserted-by":"crossref","first-page":"14902","DOI":"10.3390\/molecules190914902","article-title":"1,4-naphthoquinones: from oxidative damage to cellular and inter-cellular signaling","volume":"19","author":"Klotz","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2018.03.024_bib51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1568026615666141209155300","article-title":"Electrochemically driven supramolecular interaction of quinones and ferrocifens: an example of redox activation of bioactive compounds","volume":"15","author":"de Paiva","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib52","doi-asserted-by":"crossref","first-page":"11557","DOI":"10.1021\/ja201729z","article-title":"Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones \u2013 a new strategy to combat malarial parasites","volume":"133","author":"M\u00fcller","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.micpath.2018.03.024_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bmc.2003.10.022","article-title":"Quantitative structure-activity relationship in aziridinyl-1,4-naphthoquinone antimalarials: study of theoretical correlations by the PM3 method","volume":"12","author":"Dos Santos","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib54","doi-asserted-by":"crossref","first-page":"248","DOI":"10.17533\/udea.vitae.17322","article-title":"Naphthoquinones: biological properties and synthesis of lawsone and derivatives \u2013 a structure review","volume":"3","author":"L\u00f3pez","year":"2014","journal-title":"Vitae"},{"key":"10.1016\/j.micpath.2018.03.024_bib55","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejmech.2013.01.010","article-title":"Synthesis using microwave irradiation and antibacterial evaluation of new N,O-acetals and N,S-acetals derived from 2-amino-1,4-naphthoquinones","volume":"63","author":"Jord\u00e3o","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib56","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ejmech.2016.10.034","article-title":"New family of antimicrobial agents derived from 1,4-naphthoquinone","volume":"29","author":"Janeczko","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024098","article-title":"Is nitric oxide decrease observed with naphthoquinones in LPS stimulated RAW 264.7 macrophages a beneficial property?","volume":"6","author":"Pinho","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2018.03.024_bib58","doi-asserted-by":"crossref","first-page":"150015","DOI":"10.1098\/rsob.150015","article-title":"Targeting of Helicobacter pylori thymidylate synthase ThyX by non-mitotoxic hydroxy-naphthoquinones","volume":"5","author":"Skouloubris","year":"2015","journal-title":"Open Biol."},{"key":"10.1016\/j.micpath.2018.03.024_bib59","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1074\/jbc.M112.419069","article-title":"The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action","volume":"288","author":"Karkare","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib60","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jam.13369","article-title":"Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds","volume":"122","author":"Moreira","year":"2016","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2018.03.024_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2012.10.052","article-title":"Addition of thiols to o-quinone methide: new 2-hydroxy-3-phenylsulfanylmethyl[1,4]naphthoquinones and their activity against the human malaria parasite Plasmodium falciparum (3D7)","volume":"59","author":"Sharma","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2018.03.024_bib62","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1086\/432515","article-title":"The predominant variant of the Brazilian epidemic clonal complex of methicillin-resistant Staphylococcus aureus has an enhanced ability to produce biofilm and to adhere to and invade airway epithelial cells","volume":"192","author":"Amaral","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.03.024_bib63","article-title":"Complete genome sequence of a variant of the methicillin-resistant Staphylococcus aureus ST239 lineage, strain BMB9393, displaying superior ability to accumulate ica-independent biofilm","volume":"8","author":"Costa","year":"2013","journal-title":"Genome Announc."},{"key":"10.1016\/j.micpath.2018.03.024_bib64","volume":"353","author":"Clinical and Laboratory Standard Institute, CLSI","year":"2015"},{"key":"10.1016\/j.micpath.2018.03.024_bib65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2180-13-93","article-title":"Impact of agr dysfunction on virulence profiles and infections associated with a novel methicillin-resistant Staphylococcus aureus (MRSA) variant of the lineage ST1-SCCmec IV","volume":"13","author":"Ferreira","year":"2013","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2018.03.024_bib66","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.thromres.2014.05.009","article-title":"In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems: determination of novel NAH derivatives antiplatelet and nanotechnological approach","volume":"134","author":"Sathler","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.micpath.2018.03.024_bib67","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.micpath.2018.03.024_bib68","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/nl0805615","article-title":"Method for analysis of nanoparticle hemolytic properties in vitro","volume":"8","author":"Dobrovolskaia","year":"2008","journal-title":"Nano Lett."},{"key":"10.1016\/j.micpath.2018.03.024_bib69","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/phar.1636","article-title":"Infections caused by resistant Gram-negative bacteria: epidemiology and management","volume":"35","author":"Kaye","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.micpath.2018.03.024_bib70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fcimb.2017.00039","article-title":"Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence","volume":"7","author":"Moradali","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2018.03.024_bib71","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/s41598-017-03656-2","article-title":"Streptococcus sp. in neonatal endotracheal tube biofilms is associated with ventilator-associated pneumonia and enhanced biofilm formation of Pseudomonas aeruginosa PAO1","volume":"7","author":"Pan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2018.03.024_bib72","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.colsurfb.2017.05.029","article-title":"Anti-biofilm effect of dihydromyricetin-loaded nanocapsules on urinary catheter infected by Pseudomonas aeruginosa","volume":"156","author":"Dalcin","year":"2017","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.micpath.2018.03.024_bib73","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1590\/1678-775720160032","article-title":"Occurrence and antimicrobial susceptibility of enteric rods and pseudomonads isolated from the dental prostheses biofilm","volume":"24","author":"Silva","year":"2016","journal-title":"J. Appl. Oral Sci."},{"key":"10.1016\/j.micpath.2018.03.024_bib74","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10096-015-2323-z","article-title":"Biofilm-specific antibiotic tolerance and resistance","volume":"34","author":"Olsen","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.03.024_bib75","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.coph.2013.07.004","article-title":"Biologically inspired strategies for combating bacterial biofilms","volume":"13","author":"Blackledge","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.micpath.2018.03.024_bib76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jgar.2017.04.008","article-title":"Deficiency of quorum sensing system inhibits the resistance selection of Pseudomonas aeruginosa to ciprofloxacin and levofloxacin in vitro","volume":"10","author":"Gao","year":"2017","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.micpath.2018.03.024_bib77","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1574-695X.2011.00858.x","article-title":"Combating biofilms","volume":"65","author":"Yang","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.micpath.2018.03.024_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1574-6941.12344","article-title":"Pseudomonas biofilms: possibilities of their control","volume":"89","author":"Masak","year":"2014","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.micpath.2018.03.024_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006504","article-title":"The RhlR quorum-sensing receptor controls Pseudomonas aeruginosa pathogenesis and biofilm development independently of its canonical homoserine lactone autoinducer","volume":"13","author":"Mukherjee","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2018.03.024_bib80","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.280.5361.295","article-title":"The involvement of cell-to-cell signals in the development of a bacterial biofilm","volume":"280","author":"Davies","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.micpath.2018.03.024_bib81","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/AEM.67.4.1865-1873.2001","article-title":"Quorum-sensing genes in Pseudomonas aeruginosa biofilms: their role and expression patterns","volume":"67","author":"Kievit","year":"2001","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micpath.2018.03.024_bib82","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jat.1206","article-title":"Structure-activity relationships in the haemolytic activity and nephrotoxicity of derivatives of 1,2- and 1,4-naphthoquinone","volume":"27","author":"Munday","year":"2007","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.micpath.2018.03.024_bib83","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.micpath.2018.03.024_bib84","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","article-title":"Characteristics of compounds that cross the blood-brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC Neurol."},{"key":"10.1016\/j.micpath.2018.03.024_bib85","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/pds.3199","article-title":"Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in the health improvement network","volume":"21","author":"Rowan","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.micpath.2018.03.024_bib86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-1218(83)90182-9","article-title":"Mutagenicity of natural naphthoquinones and benzoquinone in the Salmonella\/microsome test","volume":"124","author":"Tikkanen","year":"1983","journal-title":"Mutat. Res."},{"key":"10.1016\/j.micpath.2018.03.024_bib87","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1073\/pnas.81.6.1696","article-title":"Mutagenicity of quinones: pathways of metabolic activation and detoxification","volume":"81","author":"Chesis","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.micpath.2018.03.024_bib88","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/tx00040a012","article-title":"Mutagenicity and cytotoxicity of naphthoquinones for Ames Salmonella tester strains","volume":"7","author":"Hakura","year":"1994","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.micpath.2018.03.024_bib89","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cbdd.12255","article-title":"Beyond topoisomerase inhibition: antitumor 1,4-naphthoquinones as potential inhibitors of human monoamine oxidase","volume":"83","author":"Coelho-Cerqueira","year":"2014","journal-title":"Chem. Biol. Drug Des."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018300317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018300317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T23:14:32Z","timestamp":1719875672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401018300317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":89,"alternative-id":["S0882401018300317"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2018.03.024","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2018.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}